In 2018 when Minh-Chau Le was a brand-new transactions partner, the first deal she led on her own was representing Genstar Capital as it acquired a majority stake in Advarra, Inc., a company that provides clinical research compliance services. As part of that transaction, she went on to help Advarra acquire companies itself so that the final deal was worth about $5 billion.
“I was with Advarra from the very start,” Le said, and she worked w...
To continue reading, please subscribe.
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$795 for an entire year!
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$795 for an entire year!
Or access this article for $45
(Purchase provides 7-day access to this article. Printing, posting or downloading is not allowed.)
Already a subscriber?
Sign In